AUROPHARMA
Aurobindo Pharma Ltd.
Latest scanner signal, chart levels and stage timeline for AUROPHARMA. Research only, not advice.
Copied
Latest status
Breakout
Moderate
Scan date 2026-05-08
₹1490.9
Latest price
60.0
Latest scanner score
10
Saved appearances
large_mid
Healthcare
Scanner Stage Timeline
2026-05-03
Appeared in pre-breakout scanner
Days:
5
Price then:
₹1389.5
2026-05-05
Moved into breakout scanner
Days:
3
Price then:
₹1429.9
Daily Chart
Levels are generated from the latest scanner row.
Results & Fundamentals Lens
Steady cadence
Latest quarterly snapshot saved for AUROPHARMA. Use it with price action, not as standalone advice.
Acceleration
Stable
Quarter ended 2025-12-31
Revenue YoY
Top-line growth vs same quarter last year
+12.5%
Revenue QoQ
Sequential sales momentum
+10.4%
EPS YoY
Profit growth vs same quarter last year
+11.9%
EPS QoQ
Sequential earnings momentum
+10.4%
What to notice
Growth is not explosive — lean more on structure, volume, and market tone; the tape matters more than the print.
YoY and QoQ deltas benchmark the latest reported quarter ending 2025-12-31.
Detailed Scanner Breakdown
Detailed fields from the latest pre-breakout row.
Very Strong · 86.9
Volume Profile neutral
POC₹1299.41
VAH₹1447.56
VAL₹1188.3
Vol above POC45.3%
Institutional Activity — Heavy Accumulation
Avg cost basis₹1291.69
Acc zone₹1162.4–1489.7
Power buy days3
CMF0.17
18.0
VCP
/28
3.0
Handle
/12
15.0
Stage
/18
30.0
RS
/22
17.0
Setup
/12
15.0
Volume
/8
75.0
Inst
/100
Price
₹1489.0
Stage
Stage 2
RS trend
Constructive
Sector RS
10.2%
Base
16w / 26.9%
Base quality
62.0
Vol quality
27.0
Failure risk
8.0
RS rank
74.4
RSI
68.0
ADX
21.6
Avg value
₹232.6 Cr
Distribution
3 day(s)
VCP
–
Vol dry
No
Flags
None
Scanner Notes
✓ AT PIVOT — breakout imminent
✓ Handle — weak hands shaken out, coil tightened further
✓ RS rank 74 — NSE sweet spot (70-80 zone, 43% historical win rate)
✓ RS LINE AT ALL-TIME HIGH — stock leading market even while in base (O'Neil's #1 signal)
✓ Within 3% of 52w high — on cusp of new highs
✓ Sector 'Healthcare' leading +10%
✓ GMMA PERFECT: all EMAs aligned + both compressed (S:3.6% L:3.8%) — EXPLOSIVE SETUP
✓ OBV rising in base — institutions accumulating silently
✓ Heavy institutional accumulation (CMF=0.17, 3 power days)
✓ Pocket Pivot — institutional burst buying in base, can't be hidden
✓ A/D Rating A+ (9U/3D, 13wk) — heavy institutional accumulation
✓ Rising lows: 6/7 weeks — higher lows, buyers stepping up
✓ Weekly chart: 9/12 bullish closes — institutional buying on weekly
✓ MACD zero-cross inside base (+8pts) — NSE's strongest pre-breakout signal (+8% edge from research)
Related Stocks
Same sector or industry, ranked by latest pre-breakout score.
NATCOPHARM
NATCO Pharma Ltd.
Very Strong
96.6
STAR
Strides Pharma Science Ltd.
Very Strong
91.2
LAURUSLABS
Laurus Labs Ltd.
Very Strong
86.5
SAILIFE
Sai Life Sciences Ltd.
Very Strong
86.5
GLENMARK
Glenmark Pharmaceuticals Ltd.
Very Strong
83.5
JBCHEPHARM
J.B. Chemicals & Pharmaceuticals Ltd.
Very Strong
80.5
ACUTAAS
Acutaas Chemicals Ltd.
Strong
78.8
ASTERDM
Aster DM Healthcare Ltd.
Strong
78.5